Cargando…
The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering
Despite decades of intensive attention directed to creation of genetically altered cells (e.g., as in development of chimeric antigen receptor (CAR) T-cells) and/or to achieve requisite in vitro accumulation of desired immunologic effectors (e.g., elaboration of virus-specific T cells, expansion of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336727/ https://www.ncbi.nlm.nih.gov/pubmed/30687313 http://dx.doi.org/10.3389/fimmu.2018.03084 |